Effect of Atomoxetine and Oxybutynin on Phenotype Traits and OSA Severity
Latest Information Update: 31 Jan 2019
At a glance
- Drugs Atomoxetine (Primary) ; Oxybutynin (Primary)
- Indications Sleep apnoea syndrome
- Focus Therapeutic Use
- Acronyms ATOSA
- 05 Nov 2018 Results published in the American Journal of Respiratory and Critical Care Medicine
- 17 Jan 2018 Status changed from recruiting to completed.
- 21 Feb 2017 Planned End Date changed from 1 Mar 2017 to 1 Mar 2018.